Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model
OncoImmunology | October 1, 2020 | Volume: 9 | Issue: 1 | Pages: No page available
10.1080/2162402x.2020.1818437
| PMID 33117602